Wang, Jieru
Liu, Li
Li, Jia
Feng, Xiaomeng
Yi, Huiming
Jiang, Erlie
Zheng, Yizhou
Zhang, Fengkui
Zhu, Xiaofan
Mi, Yingchang
Han, Mingzhe
Wang, Jianxiang
Feng, Sizhou https://orcid.org/0000-0003-2768-6690
Funding for this research was provided by:
Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences and Peking Union Medical College (2021-I2M-1-017)
Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (2021-I2M-C&T-B-080)
Haihe Laboratory of Cell Ecosystem Innovation Fund (22HHXBSS00036)
Tianjin Municipal Science and Technology Commission Grant (21JCZDJC01170)
Article History
Received: 6 June 2024
Accepted: 2 July 2024
First Online: 1 August 2024
Declarations
:
: The authors have no relevant financial or non-financial interests to disclose.
: This study was approved by the Institutional Review Board (or Ethics Committee) of Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College (Ethics approval reference number: NICHE-BDI).
: Informed consent was obtained from all individual participants included in the study.
: Preliminary data from this study have previously been presented at the European Hematology Association (EHA) 2023 Hybrid Congress in Germany on June 8th 2023 (Publication Number: P1511), and at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition in California on December 9th 2023 (Publication Number: 2163).